PROGETTAZIONE E SVILUPPO DEL FARMACOModule MODULO 2 FARMACOLOGIA
Academic Year 2024/2025 - Teacher: CARMELA PARENTIExpected Learning Outcomes
At the end of the course, to pass the exam, the student must demonstrate that he/she has acquired:
• the terminology and basic concepts related to the tests normally performed in the preclinical screening of a new drug.
• the basic concepts and key words of the different phases of the clinical trial of a drug.
Course Structure
Required Prerequisites
Attendance of Lessons
Detailed Course Content
Program
Preclinical studies: (2 cfu):
• Biochemical and physiological effects of a drug and molecular mechanisms through which these effects are produced (pharmacodynamics)
-->• In vitro and in vivo studies for the pharmacological characterization of a drug
• Concept of selectivity, affinity, efficacy and potency of a drug
• Principles of acute and chronic toxicity
• Absorption, distribution in organs, tissues and cells, metabolic transformations and pathways and methods of elimination of a drug
- Methodologies for the pharmacokinetic characterization of a drug
Clinical trials (1cfu):
• General principles and purposes of clinical trials
• Rules of good clinical practice
• Clinical research protocols
• Phases of clinical trials
• The actors of clinical trials: participants, sponsors, contract research organizations and regulatory agencies. Ethics committees, protocol and informed consent.
-->Textbook Information
Clementi, Fumagalli: Farmacologia generale e molecolare
Annunziato, Di Rienzo: Trattato di Farmacologia
Course Planning
| Subjects | Text References | |
|---|---|---|
| 1 | • Biochemical and physiological effects of a drug and molecular mechanisms through which these effects are produced (pharmacodynamics)• | Annunziato, Di Rienzo: Trattato di Farmacologia |
| 2 | In vitro and in vivo studies for the pharmacological characterization of a drug | Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia |
| 3 | Concept of selectivity, affinity, efficacy and potency of a drug | Annunziato, Di Rienzo: Trattato di Farmacologia |
| 4 | Principles of acute and chronic toxicity | Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia |
| 5 | Absorption, distribution in organs, tissues and cells, metabolic transformations and pathways and methods of elimination of a drug | Annunziato, Di Rienzo: Trattato di Farmacologia |
| 6 | Methodologies for the pharmacokinetic characterization of a drug | Annunziato, Di Rienzo: Trattato di Farmacologia |
| 7 | Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia | |
| 8 | Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia | |
| 9 | Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia | |
| 10 | Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia | |
| 11 | Clementi, Fumagalli: Farmacologia generale e molecolareAnnunziato, Di Rienzo: Trattato di Farmacologia |
Learning Assessment
Learning Assessment Procedures
Examples of frequently asked questions and / or exercises
How are preclinical studies related to ADME conducted?
Who is the Ethics Committee composed of and what are its functions?
How are Phase I clinical studies conducted?
What is a bias?